Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE.
Heart. 2011 Jul;97(14):1175-81.
Related citations
Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.
Bouillon K, Singh-Manoux A, Jokela M, Shipley MJ, Batty GD, Brunner EJ, Sabia S, Tabák AG, Akbaraly T, Ferrie JE, Kivimäki M.
Heart. 2011 Jun;97(11):923-30. Epub 2011 Apr 12.
CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia.
Neefjes LA, Ten Kate GJ, Rossi A, Galema-Boers AJ, Langendonk JG, Weustink AC, Moelker A, Nieman K, Mollet NR, Krestin GP, Sijbrands EJ, de Feyter PJ.
Heart. 2011 Jul;97(14):1151-7. Epub 2011 May 12.
Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient.
Watts GF, Karpe F.
Heart. 2011 Mar;97(5):350-6. Review.
Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation.
Logue J, Murray HM, Welsh P, Shepherd J, Packard C, Macfarlane P, Cobbe S, Ford I, Sattar N.
Heart. 2011 Apr;97(7):564-8. Epub 2011 Feb 14.
Controversies in the cardiovascular management of type 2 diabetes.
Opie LH, Yellon DM, Gersh BJ.
Heart. 2011 Jan;97(1):6-14. Epub 2010 Nov 23. Review.
Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular Project (DIVA).
Henrotin JB, Zeller M, Lorgis L, Cottin Y, Giroud M, Béjot Y.
Heart. 2010 Dec;96(24):1990-6. Epub 2010 Aug 11.
Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P; EUROASPIRE Study Group.
Heart. 2010 Nov;96(21):1744-9.
Inorganic nitrate and the cardiovascular system.
Kapil V, Webb AJ, Ahluwalia A.
Heart. 2010 Nov;96(21):1703-9. Epub 2010 Aug 23. Review.
Progression of preclinical diastolic dysfunction to the development of symptoms.
Correa de Sa DD, Hodge DO, Slusser JP, Redfield MM, Simari RD, Burnett JC, Chen HH.
Heart. 2010 Apr;96(7):528-32.
Which lipid fraction is the target and how often should this be monitored?
Thompson G.
Heart. 2010 Mar;96(6):413-4. No abstract available.
Lipid re-screening: what is the best measure and interval?
Takahashi O, Glasziou PP, Perera R, Shimbo T, Suwa J, Hiramatsu S, Fukui T.
Heart. 2010 Mar;96(6):448-52. Epub 2009 Jun 14.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on